VDSC, MJNA & Extended Watchlist

ALAS International Holdings, Inc. VDSC

After a slightly rocky start yesterday morning in which it pulled back to .0128, VDSC surged back, gaining 28% as it touched .0164 in the afternoon, and closed with strength near that high of day (.016). We pointed out on the chart yesterday that a Golden Cross was imminent, and that occurred as well.

We are going to be keeping a keen eye on this stock today as well, although it has already seen four consecutive days of gains, so the time for locking in profits could be close-at-hand.

BARCHART.COM is currently giving VDSC an 88% Overall “Buy” Rating

Medical Marijuana, Inc. MJNA

We’ve had this stock on our radar for over a year now. Following an alert on August 9th , it was trading as low as .032. By mid-February, we witnessed a surge to as high as .50, for an overall increase of 1463%!

Since that time, it had been in an overall downtrend until just recently falling back to the twelve-cent range. The stock has now begun to show signs of recovery, and our focus has been drawn back to MJNA due to the current setup on the chart. As we’ve pointed out below, there is a promising look to it, with the MACD having just crossed. We’d like to see it continue to hold support off of the 200DMA and 20DMA (.152 & .189 respectively) and start to push towards that 50DMA at .238.

We also wanted to talk about this old favorite of ours as the company has just released its updated quarterly report which boasts higher-than-projected net income:

Operating highlights of the quarter were as follows:

Expanded its portfolio of innovated cannabinoid based phyto-medical companies with an investment in KannaLife Sciences. KannaLife Sciences, Inc. is a late stage bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants.

KannaLife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the Commercialization of U.S. Patent 6,630,507 “Cannabinoids as Antioxidants and Neuroprotectants” (the “‘507 Patent”).

Dixie brand received national exposure in Fortune Magazine, Boston Globe, Martha’s Vinyard Times, USA Today, Fast Company, Channel 5 Boston, increasing public awareness for the Company and its brands.

Dixie brand continued product development and captured additional market share. Currently Dixie services an estimated 90% of the addressable market based on the number of available accounts\retail outlets in Colorado.

…More highlights in the Full Report>>

Extended Watchlist: